Stay updated on CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.

Latest updates to the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedSystem update: Revision to v3.4.2 has been applied. No changes to the study content or layout are observed, and prior funding-status notices have been removed.SummaryDifference0.4%

- Check15 days agoChange DetectedAdded a government funding–lapse notice noting the NIH Clinical Center is open and that operating status information is available at opm.gov, and updated the site version to v3.4.1 (removing v3.4.0).SummaryDifference0.4%

- Check22 days agoChange DetectedMinor UI/metadata updates, including a 'Show glossary' option, a 'No FEAR Act Data' disclosure, a new 'Revision: v3.4.0' tag, and changes to capitalization/labeling of QC Criteria-related text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedA new Revision: v3.3.4 label appears on the page, replacing the previous Revision: v3.3.3. This change does not alter study content, endpoints, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a Locations section listing Pennsylvania as a site. The HHS Vulnerability Disclosure was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check86 days agoChange DetectedAdded clarifications that publications are provided voluntarily by the study team and are auto-filled from PubMed, and noted a revision tag (Revision: v3.3.2). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CMP-001 Combo With Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 Combo With Nivolumab in Melanoma Clinical Trial page.